Skip to Content
 

News: Host-Tumor Interactions Research Program

Richmond receives legacy award from Society for Leukocyte Biology

Thursday, December 12th, 2019

Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.

Project seeks new way to assess immunotherapy effectiveness

Thursday, November 7th, 2019

GE Healthcare has awarded researchers $2.5 million in funding to develop PET tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.

Rathmell lands award from Lupus Research Alliance

Thursday, October 31st, 2019

Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.

Pietenpol, Wilson land Komen cancer research support

Thursday, October 24th, 2019

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Potential second-line melanoma treatment identified

Friday, August 30th, 2019

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

New window on fibrosis

Friday, August 9th, 2019

A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.

Center for Immunobiology grows, bolsters program

Friday, July 19th, 2019

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Vanderbilt vaccine pioneer James Crowe honored with major science prize

Thursday, July 11th, 2019

James Crowe Jr., MD, has been honored by the science and technology company Merck KGaA, Darmstadt, Germany for his contributions to developing new therapeutics and vaccines against some of the world’s deadliest viruses.

Study identifies critical regulator of tumor-specific T cell differentiation

Saturday, June 29th, 2019

A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work

Gore, King elected to 2019 IAMBE Class of Fellows

Thursday, May 30th, 2019

John Gore, PhD, director of the Vanderbilt University Institute of Imaging Science (VUIIS), and Michael King, PhD, J. Lawrence Wilson Professor and chair of the Department of Biomedical Engineering at Vanderbilt University, were recently elected to the International Academy of Medical and Biological Engineering (IAMBE) 2019 Class of Fellows in recognition of their contributions in the field of medical and biological engineering.

Next Page »